#merkel cell carcinoma

[numberlover1729]

pour one out for him

take his ass to margaritaville

[geipetreatment]

Demystifying Merkel Cell Carcinoma: Understanding the Basics

Because it is uncommon and has characteristics comparable to other skin disorders, Merkel Cell Carcinoma (MCC) is an aggressive form of skin cancer that frequently goes undetected or is misdiagnosed. So understanding the fundamentals of Merkel Cell Carcinoma is essential for timely diagnosis, effective therapy or treatment, and better results. 

[cancertreatmentsstuff]

What Is Merkel Cell Carcinoma and How to Prevent It

Looking for a scientific, effective, non-surgical, non-toxic & low-cost Merkel Cell Carcinoma Treatment? A rare kind of skin cancer called Merkel cell carcinoma (MCC) has a propensity to migrate beyond the skin and tends to grow quickly.

[colinwilson11]

Merkel Cell Carcinoma Market To Grow At Highest Pace Owing To Rising Incidence Of Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a rare form of skin cancer that forms in the skin cells known as Merkel cells or touch receptors. It often appears as a solitary red, purple, or skin-colored nodule on sun-exposed areas such as the head and neck regions. MCC grows and spreads rapidly causing swelling of nearby lymph nodes. Merkel cell carcinoma treatment includes radiation therapy, chemotherapy, and surgery. Depending on the stage of the cancer, treatment options may involve a combination of these therapies.

The Merkel Cell Carcinoma Market  is estimated to be valued at US$ 2.51 Bn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Merkel Cell Carcinoma Market are Merck, Incyte Corporation, Kartos Therapeutics, Inc., Bristol-Myers Squibb, and Amgen Inc. Merck and Incyte Corporation are leading pharmaceutical companies offering immunotherapies for Merkel cell carcinoma treatment.

Rising incidence of Merkel cell carcinoma worldwide is a key factor driving the market growth. According to studies, MCC incidence rates have tripled over the past 20 years. Increasing exposure to ultraviolet radiation from sun exposure is contributing to the rising caseload of MCC.

Ongoing research and development activities for developing effective treatment options is fueling market growth. Pharmaceutical companies are engaged in developing monoclonal antibody therapies, immune checkpoint inhibitors, and combination therapies to improve treatment outcomes in Merkel cell carcinoma.

Market Trends

Growing preference for targeted therapy - Introduction of immune checkpoint inhibitors and targeted monoclonal antibody therapies is revolutionizing Merkel cell carcinoma treatment. Drugs like avelumab and pembrolizumab offer more efficacious treatment with fewer side effects compared to chemotherapy.

Rising focus on combination therapies - Combination of chemotherapy with immunotherapy is emerging as a promising treatment approach. Ongoing clinical trials are evaluating efficacy of combining chemotherapies like cisplatin with immune checkpoint inhibitors. Such combination regimens may achieve high response rates.

Market Opportunities

Development of novel drug candidates - Several biotech companies are working on developing novel drug candidates like anti-PD-L1 monoclonal antibodies, vaccines, and oncolytic virus therapies to treat Merkel cell carcinoma. Success of such candidates can reap high returns.

Increasing screening and early diagnosis - Initiatives to raise awareness about MCC and incorporate screening of high-risk groups can help detect MCC at early stages. This provides scope for intervening with curative therapies.

Impact Of COVID-19 On Merkel Cell Carcinoma Market Growth

The COVID-19 pandemic posed significant challenges for the Merkel cell carcinoma market. During the initial phases of the pandemic, patients avoided or delayed medical care due to fears of virus exposure or lockdowns, resulting in delayed diagnosis and treatment of Merkel cell carcinoma. This negatively impacted market growth in the short term. However, as the healthcare systems adapted to the pandemic by implementing strict safety protocols, the number of patients seeking treatment gradually increased. Though the market experienced a temporary dip, the long term impact is expected to be marginal. As the focus shifts to post-COVID recovery, efforts must be made to promote early detection and ensure uninterrupted access to care. Teleoncology can help maintain patient engagement and support. Vaccination drives must continue to alleviate pressure on hospitals and enable prioritization of cancer treatment. With prudent strategies, the market is well-positioned to get back on its pre-pandemic growth trajectory.

Geographical Regions With High Merkel Cell Carcinoma Market Valve Concentration

The United States represents the largest geographical market for Merkel cell carcinoma treatment in terms of value. This is primarily due to the high prevalence of the disease and well-developed healthcare infrastructure in the country. Within the US, states like Florida, California and Arizona have emerged as major hotspots with higher caseloads. These southern regions experience warmer and sunnier weather for most part of the year. Extensive sun exposure increases risk and has contributed to US retaining its top position. Europe is the second largest regional market led by markets like Germany, United Kingdom and France. However, the Asia Pacific region is witnessing fastest market growth driven by improving access to healthcare in India and China. Rising awareness among physicians and public regarding early detection is further propelling the APAC market.

Get more insights on this topic: https://www.ukwebwire.com/merkel-cell-carcinoma-market-poised-for-growth-due-to-advancements-in-targeted-cancer-therapies/

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

 What Are The Key Data Covered In This Merkel Cell Carcinoma Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Merkel Cell Carcinoma Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Merkel Cell Carcinoma Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Merkel Cell Carcinoma Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Merkel Cell Carcinoma Market vendors

FAQ’s

Q.1 What are the main factors influencing the Merkel Cell Carcinoma Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Merkel Cell Carcinoma Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Merkel Cell Carcinoma Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

[avaantares]

Going to expand a bit on the "or else."

I was at a group thing the other day and heard someone older (sixties-seventies, not sure of her exact age) asking another woman where she'd gone for vacation because she had such a nice "healthy tan."

I cringed just hearing that phrase -- an advertising myth from a bygone era, which survived longer than its contemporaries such as "cigarettes are good for you" and "children should eat more lard." I'd just finished sorting some publications for a sale, and I read an article in one of them that forcefully reiterated how there was no such thing as a "healthy" tan, all tanning is a sign of irreversible skin damage, and we should all be wearing sunscreen daily to stave off deadly skin cancers -- the diagnosis of which was climbing at record rates compared to other types of cancer.

This article was published in 1990.

We've known since well before the invention of the World Wide Web that unprotected sun exposure can actually kill you, and yet people are still going out without sunscreen -- or even deliberately tanning because "I just want to look good for the wedding," or "I'll get a little tan first so I don't burn," or whatever reason.

Everyone's skin can be damaged by the sun, regardless of skin color or pigmentation. The results of cumulative sun damage aren't just freckles or dryness or leathery texture -- it can be basal cell carcinoma, or melanoma, or squamous cell carcinoma, or even merkel cell carcinoma, which is the deadliest form and often metastasizes to other organs, such as the brain or lungs. (Even when treated successfully, it has a ~40% chance of recurring within 3 years.)

If it sounds like I'm trying to scare you... well, I am. I've had numerous family members and acquaintances diagnosed with skin cancer. Sunscreen (or equivalent gear; see below) is cheap insurance, and it could literally save your life.

Choosing a sunscreen

Not all sunscreens are created equal. Mineral sunscreens (those made with zinc oxide or titanium dioxide) are generally better choices; they're more shelf-stable than chemical sunscreens, and offer full-spectrum protection. They're also better for the planet -- most chemical sunscreens are actually toxic to marine life and coral reefs, and should never be used at the beach or around waterways. (Some sunscreens advertise "reef-safe" or "reef-friendly," but those terms are unregulated, so anyone can use them regardless of ingredients. Here's a guide to choosing a true reef-safe product.)

Chemical sunscreens that contain active ingredients such as homosalate, avobenzone and oxybenzone offer full-spectrum protection when new, but only remain at peak effectiveness for a few months in storage (and break down more quickly in high-temperature environments, such as a hot car). Chemical sunscreens should not be stored from year to year. If you have chemical sunscreen left over from a previous year, it's probably expired and will not provide full protection.

Both kinds of sunscreens come in a variety of forms, including sprays, creams, liquids, and solid sticks that you can apply as needed. Choose the type that works best for your own skin and convenience.

For daily use, it's a good idea to wear a sunscreen with SPF rating of at least 15. A lot of daily facial moisturizers contain a light sunscreen, so you can just put that on in the morning to protect yourself from casual sun exposure. If you're going to be outside for any length of time (mowing the lawn, watching a sporting event, going for a walk, shoveling snow), go with SPF 30 or higher. (I wear SPF 50+ any time I'm planning to be outdoors, because I'm pale and at high risk.) Be sure to reapply as directed.

Free/cheap sunscreen samples

If you're worried about the cost of adding sunscreen to your daily regimen (and yes, some varieties can be pricey), here are some places you can get free or lower-cost samples to get you started. (These are USA only, since that's where I'm based, but you can Google "free sunscreen sample" to check what's available in your region.)

LaRoche-Posay Anthelios Melt-In Milk SPF 60 free sample request form, no purchase necessary!

Suntegrity has lower-cost ($2-$7) samples of their tinted SPF 30 sunscreen products

PinchMe offers rotating free product samples such as this sunscreen that you can claim at no charge

DailyGoodieBox also has products on rotation, but they sometimes offer skin care boxes that include sunscreen

Sephora stores offer free take-home samples of nearly every product they sell, including a lot of sunscreen moisturizers; visit a local store if you have one. If you place an online order, you can also add up to three free product samples to your order (online sample products rotate, but there's usually at least one sunscreen product). They also periodically offer sunscreen sample packs that you can purchase at a reduced price to try new products.

Ulta Beauty has a free membership program that sends you a free gift and/or product samples on your birthday; they often have sunscreen available

LOTS of sunscreen companies offer free sunscreen wipes or sample packs at large events such as state fairs, concert festivals, sporting events, etc., so keep an eye out if you go to a big outdoor event!

"...But I HATE the texture/smell/whatever of sunscreen!"

If you don't like the idea of slathering your body in sunscreen, there are other sun protection options available. One of my go-tos is UPF-rated clothing. Whenever I know I'm going to be out in direct sun all day, I wear a long-sleeved, zip-up UPF 50 swim shirt that provides the same or better sun protection as wearing SPF 50 sunscreen. Because it's a thin, lightweight material designed for swimming, it's not hot -- I even wore it in the Sahara desert.

(It's a selfie, so you can't see much of the shirt, but I wore this thing all over Egypt, Jordan, Türkiye and Greece. I also wear it for, y'know, actual swimming.)

UPF shirts come in many styles, with and without zippers, pockets, or hoods:

UPF clothing is sold at sporting and outdoors stores (such as REI), as well as on Amazon and other retail sites. Depending on style and features, they run between $20-$60 -- or about the cost of two to four tubes of sunscreen. I paid about $25 for mine several years ago, and I've DEFINITELY gotten my money's worth out of it.

While it's still best to wear sunscreen on any exposed skin (including ears and lips!) when outdoors, you can also reduce direct sun on your face by wearing a broad-brimmed hat. Try to choose one that's solid material, rather than a straw hat with open weaving or holes that allow sunlight through.

In conclusion...

None of us enjoys thinking and stressing about all the ways our environment is trying to kill us, but using sun protection is a simple habit to get into, and it's an easy way to stay safe while still enjoying outdoor activities.

In short: Wear sunscreen.

be pro-aging but wear sun screen. sun protection is not beauty industry propaganda it will save you. wear it. or else.

[divineacupuncturesujok]

Limited Time Offer!

Get 20% discount on skin disease treatment at Om Acupuncture, Acupressure & Sujok Therapy Center in Jaipur!

We offer treatment for a wide range of skin diseases, including:

- Acne

- Psoriasis

- Eczema (Atopic Dermatitis)

- Skin Cancer

- Melasma

- Warts

- Rosacea

- Vitiligo

- Dermatitis (Contact, Seborrheic, Stasis)

- Fungal Infections (Ringworm, Athlete's Foot)

- Alopecia Areata

- Angular Cheilitis

- Behçet's Disease

- Bowen's Disease

- Bullous Pemphigoid

- Candidiasis

- Cellulitis

- Chilblains

- Cutaneous T-Cell Lymphoma

- Darier's Disease

- Dermatofibroma

- Dyshidrotic Eczema

- Erysipelas

- Erythrasma

- Folliculitis

- Furunculosis

- Granuloma Annulare

- Hailey-Hailey Disease

- Herpes Simplex

- Hidradenitis Suppurativa

- Ichthyosis

- Impetigo

- Kaposi's Sarcoma

- Keratoacanthoma

- Keratosis Pilaris

- Lichen Planus

- Lichen Sclerosus

- Lupus

- Melanoma

- Merkel Cell Carcinoma

Our services include:

- Acupresure in Jaipur

- Acupuncture in Jaipur

- Sujok therapy center in Jaipur

- Acupresure doctor in Jaipur

- Acupuncture doctor in Jaipur

- Sujok therapy doctor in Jaipur

- Acupresure treatment center in Jaipur

- Acupuncture treatment center in Jaipur

- Sujok therapy treatment center in Jaipur

- Acupresure clinic in Jaipur

- Acupuncture clinic in Jaipur

- Sujok therapy clinic in Jaipur

- Acupresure training center in Jaipur

- Acupuncture training center in Jaipur

- Sujok therapy training center in Jaipur

Don't miss out on this amazing offer! Book your appointment today and get 20% discount on skin disease treatment.

Contact us:

Address: Near Power House, Keshav Nagar, Khora Bisal, Jaipur

Mobile Number: 7014741044

Email ID: mlsujok@gmail.com

Hurry! Offer valid for a limited time only!

[darkmaga-returns]

In January 2024, a preprint was uploaded to the bioRxiv preprint server entitled: “The SV40 virus enhancer functions as a somatic hypermutation targeting element with potential oncogenic activity”.

In a Venice.ai-summarized nutshell, the paper established the following:

The SV40 enhancer has been found to function as a somatic hypermutation-targeting element with potential oncogenic activity. This was discovered through research on the Merkel cell polyomavirus (MCPyV), which causes Merkel cell carcinoma in humans by expressing truncated large tumor antigen (LT) due to APOBEC cytidine deaminase family enzymes induced mutations. Activation-induced cytidine deaminase (AID), a member of the APOBEC family, initiates the antibody diversification process known as somatic hypermutation (SHM). The SV40 enhancer's ability to target AID and induce SHM has implications for the development of cancer and the immune system's response to pathogens.

Kevin McKernan has written an article outlining the link to cancer due to the presence of SV40 (in droves) in the modified RNA COVID-19 injectable products (Pfizer). You can read that here.

Nepetalactone Newsletter

60 Billion Oops

An X follower pointed me to this PrePrint…

Read more

2 days ago · 244 likes · 60 comments · Anandamide

Here is the phrase in the abstract of the preprint that I would like to focus on.

We demonstrate that the SV40 enhancer has strong [somatic hypermutation] (SHM) targeting activity in several cell types.

Now this is no easy subject matter to grasp - even for an immunologist - but I will do my best to describe it so that you all can understand.

One of the silver linings of the COVID scam, is that most of you probably know what antibodies are because of it. For those who do not, antibodies are secreted immunoglobulin molecules derived from the membrane-bound immunoglobulin molecules on a B cell. The process by which these antigen-specific secreted proteins are produced is quite complex. The process starts in the bone marrow, and ends up in the blood (plasma), tissue fluid, tears (mainly IgA), saliva, breast milk (colostrum, specifically) and/or lymph nodes.

[lindabrown1812]

What types of skin cancer are there, and which is the most dangerous?

Skin cancer is the most common type of cancer globally, affecting millions each year. It arises when skin cells undergo abnormal growth, often due to damage from ultraviolet (UV) radiation from the sun or tanning beds. Understanding the different types of skin cancer, their risks, and the importance of early detection can help reduce the incidence and mortality associated with this disease.

1. Basal Cell Carcinoma (BCC)

Basal Cell Carcinoma is the most common form of skin cancer, accounting for about 80% of cases. It originates in the basal cells, which are found in the lowest part of the epidermis (the outer skin layer). BCC often appears as a small, shiny bump or nodule on the skin, particularly on sun-exposed areas like the face, neck, and arms. Although BCC is slow-growing and rarely metastasizes (spreads to other parts of the body), it can cause significant damage to surrounding tissues if left untreated. Early detection and treatment are crucial to prevent complications.

2. Squamous Cell Carcinoma (SCC)

Squamous Cell Carcinoma is the second most common type of skin cancer, making up about 20% of cases. It originates in the squamous cells, which make up most of the skin’s upper layers. SCC often presents as a red, scaly patch, open sore, or wart-like growth that may crust or bleed. It typically occurs on sun-exposed areas, but it can also develop on any part of the body, including the mucous membranes and genitals. Unlike BCC, SCC has a higher risk of spreading to other parts of the body, particularly if not detected and treated early. However, with prompt treatment, the prognosis is generally good.

3. Melanoma

Melanoma is the most dangerous type of skin cancer, though it is less common than BCC and SCC. It accounts for about 1% of skin cancer cases but causes the majority of skin cancer deaths. Melanoma originates in melanocytes, the cells that produce pigment in the skin. It often appears as a new mole or a change in an existing mole, with features such as asymmetry, irregular borders, multiple colors, or a diameter larger than a pencil eraser. Melanoma can develop anywhere on the body, even in areas not exposed to the sun. It has a high propensity to spread (metastasize) to other organs, making early detection and treatment critical for survival.

4. Less Common Types

In addition to BCC, SCC, and melanoma, there are less common forms of skin cancer, such as Merkel cell carcinoma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans. These are rarer but can be aggressive and difficult to treat.

Prevention and Support

Preventing skin cancer involves protecting the skin from excessive UV radiation by wearing sunscreen, protective clothing, and avoiding tanning beds. Regular skin checks, both self-examinations and professional screenings, are vital for early detection.

For those diagnosed with skin cancer, support from cancer organizations is invaluable. Organizations like the National Coalition for Cancer Survivorship offer resources and advocacy to ensure that patients receive comprehensive care and support throughout their cancer journey. Their focus on survivorship emphasizes the importance of quality care and long-term health for those affected by cancer.

To know more visit: https://canceradvocacy.org/

[dcsi-south-florida]

Can Skin Cancer Be Deadly?

Skin cancer varies widely in terms of its threat level. Basal cell carcinoma, the most common type, is generally slow-growing and less likely to spread, but it can still cause local damage. Melanoma, on the other hand, is the most deadly form, capable of spreading quickly to other organs, leading to serious health complications or death if not treated early.

Subtypes of melanoma, including Merkel cell carcinoma and amelanotic melanoma, pose additional risks due to their aggressive nature and difficulty in detection. Effective treatments like Mohs surgery are essential for managing these cancers, particularly in sensitive areas.

Learn more about the types of skin cancer and how to protect yourself by reading the full article.

[priteshwemarketresearch]

Avelumab Market  Trends Analysis: Research Methodologies and Growth Opportunities until 2032

Avelumab Market Introduction:

Adhering to stringent rules, possessing substantial clinical trial evidence, and being committed to patient safety are considered indicators of quality in the Avelumab market. Manufacturers and other industry players place a great value on quality control processes to ensure the drug is uniform and effective. Furthermore, quality includes ongoing R&D efforts aimed at expanding Avelumab's therapeutic applications and exploring potential combinations with other medications to improve therapeutic outcomes.

Get a sample copy of this report:https://wemarketresearch.com/reports/request-free-sample-pdf/avelumab-market/1495

Avelumab Market Size And Forecast

The market is comprehensively evaluated for the predicted period in the Global Avelumab Market research. A review of the trends and other variables that are significantly influencing the market is included in each of the report's several segments. These elements, known as market dynamics, comprise the opportunities, obstacles, drivers, and constraints that shape the market and define how these elements affect it. The market's potential and challenges are extrinsic, while its drivers and restraints are intrinsic. A revenue forecast for the market's growth over the course of the forecast period is given by the Global Avelumab Market report.

Avelumab Market Trends:

A developing category of cancer treatment is cancer immunotherapy, which includes immune checkpoint inhibitors like avelumab. As immunotherapy shows promise in the fight against a variety of malignancies, this trend is anticipated to continue.

Broadening the Scope of Treatment Applications: Avelumab is now approved for Merkel-cell carcinoma and non-small cell lung carcinoma (NSCLC), but ongoing clinical trials are assessing its effectiveness in other cancer forms as well. The market might grow dramatically if these trials are successful.

Patient-Centered Care: Avelumab's capacity to selectively target particular immune pathways presents an opportunity for customized treatment strategies, which is consistent with the increasing emphasis on patient-centered care.

Avelumab Market Scope Of the Report Market Challenges:

Competitiveness: Rivalry: Avelumab's pricing and market share may be impacted by the existence of alternative immune checkpoint inhibitors.

High Cost: Due to the drug's high cost, some patients may find it difficult to afford or for healthcare systems to pay for avelumab.

Exorbitant Treatment Costs: Avelumab, like many cancer medications, is not cheap. This may restrict patient access, particularly in nations with constrained financial resources for healthcare. Care of Side Effects: Avelumab can have infusion responses and weariness as side effects, however they are usually well tolerated. It is imperative that more study be done on controlling these negative effects.

Safety Concerns: Like many potent medications, avelumab can have detrimental side effects. These can include immunological system issues, exhaustion, lung issues, and infusion responses. Physicians must assess each patient's dangers and potential advantages.

Companies Covered: Avelumab Market:

Merck

Pfizer

Others

Global Avelumab Market Segmentation:

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Avelumab market is projected to growth factors:

Increasing Cancer Rates: An older population, lifestyle choices, and more screening are all contributing contributors to the rising incidence of cancer worldwide. As a result, there is a greater chance that patients will benefit from Avelumab.

Expanding Use of Immunotherapy: The use of Avelumab in immunotherapy is one of the fastest-growing segments of cancer treatment. Avelumab may see an increase in demand as medical professionals and patients become more aware of the possible advantages of immunotherapy.

Extending Treatment Uses: Avelumab's potential application for treating other cancer types is being researched. A larger market for Avelumab would result from additional applications being approved.

Reasons Why You Should Buy This Report:

To gain an in-depth understanding of Avelumab Market

To obtain research-based business decisions and add weight to presentations and marketing strategies

To gain competitive knowledge of leading Avelumab Market players

It gives pin point investigation of changing rivalry elements and keeps you in front of contenders.

It helps in settling on educated business choices by having total bits of knowledge of market and by making inside and out investigation of market sections.

Avelumab Market Conclusion :

Riding the Immunotherapy Wave: The market gains from the increasing acceptance of cancer immunotherapy, a major driver of which is Avelumab. Given that immunotherapy is effective against a variety of malignancies, this trend is probably here to stay.

Broadening the Spectrum of Treatment: There is a great deal of room for market expansion from the ongoing clinical trials examining Avelumab's application in novel cancer kinds. The application and patient base could be greatly expanded if these trials are successful. Opening Up New Treatment Options: Avelumab's usage in experimental cancer types is being studied in ongoing clinical trials, which could lead to significant market expansion. If these trials are successful, the application and patient base could be further expanded. Regulatory Approvals: Avelumab's sales and market reach may be greatly impacted by the extension of its regulatory approvals into new indications or geographical areas.

Market Competition: #Avelumab's pricing and market share may be impacted by rival immunotherapies, conventional cancer treatments, and the introduction of biosimilars.

Contact Us: https://wemarketresearch.com/

[leedsomics]

spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis

Spatial transcriptomics (ST) is a powerful tool for understanding tissue biology and disease mechanisms. However, its potential is often underutilized due to the advanced data analysis and programming skills required. To address this, we present spatialGE, a web application that simplifies the analysis of ST data. The application spatialGE provides a user-friendly interface that guides users without programming expertise through various analysis pipelines, including quality control, normalization, domain detection, phenotyping, and multiple spatial analyses. It also enables comparative analysis among samples and supports various ST technologies. We demonstrate the utility of spatialGE through its application in studying the tumor microenvironment of melanoma brain metastasis and Merkel cell carcinoma. Our results highlight the ability of spatialGE to identify spatial gene expression patterns and enrichments, providing valuable insights into the tumor microenvironment and its utility in democratizing ST data analysis for the wider scientific community. http://dlvr.it/T95DlN

[colinwilson11]

Merkel cell carcinoma (MCC) is a rare form of skin cancer originating from neuroendocrine Merkel cells and widely believed to have a viral etiology. MCC typically presents as a firm,red nodule on sun-exposed areas of skin. With risk factors including older age,immunosuppression and UV exposure,the incidence of MCC has been rising sharply over the last two decades. Treatment involves surgery combined with potential adjuvant radiation or systemic therapy.

[nursingscience]

There are more than 100 types of cancers. Here are some cancer names which are formed in specific cells.

▪️Carcinoma: Most common type of cancer. They are formed by epithelial cells, which are the cells that cover the inside and outside surfaces of the body. Example: Bladder, kidney, breast, prostate, colon, lungs, stomach, intestine, kidney cancers are associated.

▪️Sarcoma: Sarcomas are cancers that form in bone and soft tissues, including muscle, fat, blood vessels, lymph vessels, and fibrous tissue (such as tendons and ligaments).

▪️Leukemia: Cancers that begin in the blood-forming tissue of the bone marrow are called leukemias. These cancers do not form solid tumors. Instead, large numbers of abnormal white blood cells (leukemia cells and leukemic blast cells) build up in the blood and bone marrow, crowding out normal blood cells.

▪️Lymphoma: Lymphoma is cancer that begins in lymphocytes (T cells or B cells). These are disease-fighting white blood cells that are part of the immune system. In lymphoma, abnormal lymphocytes build up in lymph nodes and lymph vessels, as well as in other organs of the body.

▪️Multiple Myeloma: Multiple myeloma is cancer that begins in plasma cells, another type of immune cell. The abnormal plasma cells, called myeloma cells, build up in the bone marrow and form tumors in bones all through the body.

▪️Melanoma: Melanoma is cancer that begins in cells that become melanocytes, which are specialized cells that make melanin (the pigment that gives skin its color). Most melanomas form on the skin, but melanomas can also form in other pigmented tissues.

▪️Brain & Spinal Cord Tumors: There are different types of brain and spinal cord tumors. These tumors are named based on the type of cell in which they formed and where the tumor first formed in the central nervous system.

▪️Germ Cells Tumors: Germ cell tumors are a type of tumor that begins in the cells that give rise to sperm or eggs. These tumors can occur almost anywhere in the body.

▪️Neuroendocrine Tumors: Neuroendocrine tumors form from cells that release hormones into the blood in response to a signal from the nervous system. These tumors, which may make higher-than-normal amounts of hormones, can cause many different symptoms. Example, islet cell tumors, medullary thyroid cancer, pheochromocytomas, neuroendocrine carcinoma of the skin (Merkel cell cancer), small cell lung cancer etc.

▪️Carcinoid Tumors: Carcinoid tumors are a type of neuroendocrine tumor. They are slow-growing tumors that are usually found in the gastrointestinal system (most often in the rectum and small intestine). Carcinoid tumors may spread to the liver or other sites in the body, and they may secrete substances such as serotonin or prostaglandins, causing carcinoid syndrome.

Source: National Cancer Institute.

[miraridoctor]

Picture this: You or a loved one has been diagnosed with Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer that can be life-threatening if left untreated. Your mind races with questions and concerns about what lies ahead. But wai... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma